M. Cobo

Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemotherapy (EURTAC) phase III randomized trial.

R. Rosell, R. Gervais, A. Vergnenègre et al. · Journal of Clinical Oncology · 2011 · 148 citations

Medicine, Oncology, Pharmacology +16

Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC

Naiyer A. Rizvi, B. Chul Cho, Niels Reinmuth et al. · Annals of Oncology · 2018 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain

Antonio Cuadrado, José R. Salcines-Caviedes, Miguel F. Carrascosa et al. · Journal of Antimicrobial Chemotherapy · 2011 · 80 citations · Full text

Veterinary Medicine, Infectious Diseases, Antimicrobial Pharmacotherapy +8

Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology

Uwe Zeymer, Peter Ludman, Nicolas Danchin et al. · European Heart Journal · 2021 · 80 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

Enric Monreal, Elena Natera‐Villalba, Álvaro Beltrán‐Corbellini et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2020 · 59 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +13